A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with poor prognosis and limited treatment options. Recent studies have reported overexpression of programmed death ligand 1 (PD-L1) in metaplastic breast cancers, and there are several reports of anti-PD-1/L1 bei...

Full description

Bibliographic Details
Main Authors: Isaac Kim, Venkatesh Rajamanickam, Brady Bernard, Brie Chun, Yaping Wu, Maritza Martel, Zhaoyu Sun, William L. Redmond, Katherine Sanchez, Reva Basho, Heather McArthur, David B. Page
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
metaplastic breast cancer
TNBC
immunotherapy
PD-L1
PI3K
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.635237/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.635237/full

Similar Items